HFA Premium Access

Improved survival with around 5 years of continuous tafamidis treatment among patients with NYHA class III transthyretin amyloid cardiomyopathy

Congress Presentation

About the speaker

Doctor Pablo Garcia-Pavia

Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid (Spain)
54 presentations

3 more presentations in this session

Outcomes of empagliflozin in patients with heart failure with a preserved ejection fraction and atrial fibrillation or atrial flutter: insights from EMPEROR-Preserved

Speaker: Professor G. Filippatos (Athens, GR)


Intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs with systolic heart failure despite long-term therapy with beta-blockers

Speaker: Professor H. Sabbah (Detroit, US)


Eplerenone versus spironolactone and outcomes in patients with heart failure: a nationwide cohort study

Speaker: Doctor J. Larsson (Copenhagen, DK)


Access the full session

Pharmacology in heart failure - what is in horizon?

Speakers: Doctor P. Garcia-Pavia, Professor G. Filippatos, Professor H. Sabbah, Doctor J. Larsson

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb